Archive: September, 2012

 

 

Australian Bioscience Fund I to invest in Sea Dragon Marine Oils

IB Australian Bioscience Fund I, managed by Octa Phillip Bioscience Managers (OPBM, formerly IB Managers) has today entered into a conditional Subscription Agreement to invest NZD$2.5 million into Claridge Capital...

Read more about Australian Bioscience Fund I to invest in Sea Dragon Marine Oils